Dr. Niranjan Naik
- Oncology and Oncosurgery
- Director , MBBS, MS,25 years of experience
- Fortis Memorial Research Institute
- Gurgaon, India
Highlights
Dr. Niranjan Naik is a well-known and respected oncologist in India. He has performed more than 12700 cancer surgeries including Breast Cancer, Thoracic, Gastro-Intestinal & Hepatobiliary Surgeries. He received training in laparoscopic cancer surgery. Currently serving as the Director of…
Treatments
- Adenocarcinoma - Glandular Cancer Treatment
- Adrenal Cancer Treatment
- Bile Duct Cancer Treatment
- Bone and Soft Tissue Cancer
- Breast Cancer
- Colo-rectal
- Gastro-Intestinal Treatment
- Hepatobilliary Surgeries
- Laparoscopic (Minimally Invasive) Cancer
- Lung Cancer Treatment
- Oesophagus Cancer Treatment
- Pancreatic Cancer
Dr. Niranjan Naik is a well-known and respected oncologist in India. He has performed more than 12700 cancer surgeries including Breast Cancer, Thoracic, Gastro-Intestinal & Hepatobiliary Surgeries. He received training in laparoscopic cancer surgery.
Currently serving as the Director of Breast & Gastro-Intestinal Onco-Surgery at Fortis Memorial Research Institute (FMRI), Gurgaon, Dr . Niranjan Naik is a prominent senior surgical oncologist. Since 1996, he has carried out more than 12000 onco-surgical procedures. Dr. Niranjan Naik has performed several difficult onco-surgical operations, including laparoscopic and thoracoscopic surgeries, successfully. Dr. Niranjan Naik is highly skilled in both therapeutic and diagnostic endoscopic treatments. Dr. Niranjan Naikhas been a guest lecturer at a number of national and international conferences.
Dr. Niranjan Naik’s Clinical Expertise
- Breast Cancer Treatment
- Thoracic (Lung & Oesophagus) Cancer
- Gastro-Intestinal Cancer
- Colo-rectal & Hepatobiliary Surgeries
- Bone and Soft Tissue Cancer Surgeries
- Laparoscopic (Minimally Invasive) Cancer Surgeries
Member of Associations
- Delhi Medical Association (DMA)
- Indian Medical Association (IMA
Where Is Dr. Niranjan Naik Currently Working
Dr. Niranjan Naik is one of the best oncologists in India and currently working at Fortis Hospital, Noida.
How Many Procedures Do Dr. Niranjan Naik Perform Till Now
Dr. Niranjan Naik has performed more than 12700 cancer surgeries including Breast Cancer, Thoracic, Gastro-Intestinal & Hepatobiliary Surgeries. Dr. Niranjan Naik has performed several difficult onco-surgical operations, including laparoscopic and thoracoscopic surgeries, successfully. Dr. Niranjan Naik is highly skilled in both therapeutic and diagnostic endoscopic treatments.
What Does Dr. Niranjan Naik Specialize in
Dr. Niranjan Naik specializes in Breast and GI Onco Surgery, Head, Neck, and Thorax Surgical Oncology, Robotic Surgery, and Surgical Oncology.
What Does a Cancer Specialist Specialize in
An important branch of medicine called oncology focuses on cancer, and an oncologist is a doctor who practices oncology. There are numerous types of oncologists. These doctors are skilled in treating a variety of tumors in different body parts of their patients.
What Is the Oncologist’s Other Name
A cancer specialist is another name for an oncologist. Medical oncology, radiation oncology, and surgical oncology are the three main subfields that make up the oncology sector in terms of treatments.
- MBBS, 1992, Bangalore Medical College, Bangalore
- MS, 1996, All India Institute of Medical Sciences, New Delhi
- Senior Consultant, Dharamshila Narayana Superspeciality Hospital , New Delhi
- Consultant, Mool Chand KR Hospital, Lajpat Nagar -III , 2004
- Consultant, Mata Chanan Devi Hospital, Janakpuri , 2004
- Consultant, Kailash Hospital, NOIDA , 2004
Breast Cancer Treatment Thoracic (Lung & Oesophagus) Gastro-Intestinal Cancer Colo-rectal & Hepatobiliary Surgeries Bone and Soft Tissue Cancer Surgeries Pancreatic Cancer Laparoscopic (Minimally Invasive) Cancer Surgeries
- Symptomatic outcome after Laparoscopic Cholecystectomy. (Prospective study of 113 patients undergoing laparoscopic cholecystectomy).
- INVESIGATOR IN PHASE III CLINICAL TRIAL:Comparative PK, Efficacy, Safety and Immunogenicity evaluation of Bmab-200 versus Herceptin®, both in combination with Docetaxel in patients with Her2+ Metastatic Breast Cancer: A Double-Blind, Randomised, Active Control, Parallel Assignment, Comparative Phase III Clinical Trial.
- GUIDE IN DIPLOMATE OF NATIONAL BOARD (DNB) SURGICAL ONCOLOGY THESIS: The role of {18F} FDG PET Scan in evaluation of clinic-pathological response of neo-adjuvant chemotherapy in locally advanced breast cancer, Chief guide, 2014-2017
- Adenocarcinoma – Glandular Cancer Treatment
- Adrenal Cancer Treatment
- Bile Duct Cancer Treatment
- Bone and Soft Tissue Cancer
- Breast Cancer
- Colo-rectal
- Gastro-Intestinal Treatment
- Hepatobilliary Surgeries
- Laparoscopic (Minimally Invasive) Cancer
- Lung Cancer Treatment
- Oesophagus Cancer Treatment
- Pancreatic Cancer